Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 38 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 9446042

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  2. US 9439976

    Compositions and methods for using cathepsin E cleavable substrates

    The Board of Regents of the University of Texas System · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  3. US 9428749

    Control of whole body energy homeostasis by microRNA regulation

    The Board of Regents of the University of Texas System · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  4. US 9422318

    Epoxyeicosatrienoic acid analogs and methods of making and using the same

    The Board of Regents of the University of Texas System · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  5. US 9422529

    Alphavirus compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  6. US 9408813

    Small-molecule inhibitors of dengue virus proteases

    The Board of Regents of the University of Texas System · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  7. US 9402850

    BAX agonist, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  8. US 9399662

    Concurrent chemotherapy and immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  9. US 9394241

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  10. US 9375475

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  11. US 9370514

    Methods for fine particle manufacture

    The Board of Regents of the University of Texas System · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  12. US 9351984

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted May 31, 2016 · Expires May 26, 2036

    granted
  13. US 9353094

    Substituted quinoxalines as kinase inhibitors

    The Board of Regents of the University of Texas System · Granted May 31, 2016 · Expires May 26, 2036

    granted
  14. US 9345790

    Cobalt-based MRI contrast agent and imaging system

    The Board of Regents of the University of Texas System · Granted May 24, 2016 · Expires May 19, 2036

    granted
  15. US 9340785

    Selective inhibition of polyglutamine protein expression

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  16. US 9340572

    Taccalonolide microtubule stabilizers

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  17. US 9339440

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  18. US 9340782

    Antimir-451 for the treatment of polycythemias

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  19. US 9333248

    Methods and composition related to Th-1 dendritic cells

    The Board of Regents of the University of Texas System · Granted May 10, 2016 · Expires May 5, 2036

    granted
  20. US 9320827

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  21. US 9314517

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  22. US 9314567

    Electro-osmotic pumps, systems, methods, and compositions

    The Board of Regents of the University of Texas System · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  23. US 9308206

    Compositions and methods for treating colon cancer

    The Board of Regents of the University of Texas System · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  24. US 9301960

    Methods for inhibiting redox-sensitive GTPases

    The Board of Regents of the University of Texas System · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted